Pharmacokinetics and Bioequivalance of Ibuprofen Tablet in Healthy Volunteers
Yuqing Xiong
Abstract
Yuqing Xiong
Abstract
Objective To investigate pharmacokinetic of Ibuprofen and to evaluate the bioequivalance.Methods Eighteen healthy male volunteers were enrolled into the single crossover study.After a single dose of the suspension equivalent to 400 mg Ibuprofen or a reference preparation were given by crossover.To develop a sensitive and specific HPLC-UV method for the determination of Ibuprofen in human plasma.The bioequivalence of the suspension and reference were evaluated by pharmacokinetic parameters and relative bioavailability obtained.Results The main pharmacokinetic parameters of test and reference Ibuprofen were as the followings:AUC 0-10 was(125.40±20.74)μg/(mL·h)and(130.38±24.79)μg/(mL·h);C max was(34.60±7.12)μg/mL and(37.88±7.13)μg/mL;T max was(2.0±0.5)h and(1.7±0.5)h;t 1/2 was(2.1±0.21)h and(2.19±0.29)h.The relative bioavailability of test to reference preparation was(98.2±18.7)%.Conclusion The two preparations are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate pharmacokinetic of Ibuprofen and to evaluate the bioequivalance.Methods Eighteen healthy male volunteers were enrolled into the single crossover study.After a single dose of the suspension equivalent to 400 mg Ibuprofen or a reference preparation were given by crossover.To develop a sensitive and specific HPLC-UV method for the determination of Ibuprofen in human plasma.The bioequivalence of the suspension and reference were evaluated by pharmacokinetic parameters and relative bioavailability obtained.Results The main pharmacokinetic parameters of test and reference Ibuprofen were as the followings:AUC 0-10 was(125.40±20.74)μg/(mL·h)and(130.38±24.79)μg/(mL·h);C max was(34.60±7.12)μg/mL and(37.88±7.13)μg/mL;T max was(2.0±0.5)h and(1.7±0.5)h;t 1/2 was(2.1±0.21)h and(2.19±0.29)h.The relative bioavailability of test to reference preparation was(98.2±18.7)%.Conclusion The two preparations are bioequivalent.
Key concepts: Bioequivalence, Pharmacokinetics, Ibuprofen, Bioavailability, Crossover study, High-performance liquid chromatography, Chromatography, Pharmacology